Work

Association Between Preoperative Fibrinogen Levels and Postoperative Morbidity and Mortality After On-Pump Cardiac Surgery: A Comparative Observational Study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background Preoperative fibrinogen concentrations may be associated with bleeding, transfusion requirements, and postoperative outcomes following cardiac surgery. However, the relationship between fibrinogen levels and postoperative morbidity remains incompletely understood. Objective This study aims to evaluate the association between preoperative fibrinogen concentrations and postoperative morbidity and mortality in patients undergoing on-pump cardiac surgery. Methods This comparative observational study was conducted at the National Institute of Cardiovascular Diseases (NICVD), Dhaka, Bangladesh, from July 2023 to June 2024. A total of 100 adult patients undergoing on-pump cardiac surgery were included and classified into two groups according to their preoperative fibrinogen concentrations: Group A, fibrinogen < 3.3 g/L (n = 50), and Group B, fibrinogen ≥ 3.3 g/L (n = 50). Continuous variables were compared using the independent-samples t-test, while categorical variables were analyzed using the chi-square test or Fisher's exact test, as appropriate. A two-sided p-value ≤ 0.05 was considered statistically significant. Results The mean preoperative fibrinogen concentrations were 2.89 ± 0.25 g/L in Group A and 4.05 ± 0.44 g/L in Group B (p < 0.001). The groups had comparable demographic characteristics and operative durations. Mean intraoperative and postoperative blood loss was significantly higher in Group B than in Group A (645.16 ± 397.86 vs. 385.90 ± 281.77 mL, p = 0.001). Whole-blood transfusion requirements were significantly higher in Group B than in Group A (3.59 ± 0.48 vs. 2.85 ± 0.74 units, p = 0.001), whereas fresh frozen plasma (FFP) requirements were significantly higher in Group B than in Group A (2.10 ± 0.64 vs. 1.42 ± 0.67 units, p = 0.001). Prolonged inotropic support involving at least two inotropic agents for more than 24 hours was significantly more frequent in Group B than in Group A (58.0% vs. 30.0%, p = 0.005). Differences in re-exploration for bleeding (14.0% vs. 2.0%, p = 0.059), acute kidney injury (AKI; 24.0% vs. 8.0%, p = 0.054), and cardiac tamponade (8.0% vs. 0%, p = 0.118) were not statistically significant. Group B also had significantly longer mean intensive care unit stays (7.56 ± 2.18 vs. 4.16 ± 1.51 days) and postoperative hospital stays (12.34 ± 3.05 vs. 8.24 ± 1.52 days) (both p < 0.001). Operative mortality occurred in 2/50 (4.0%) patients in Group B and 1/50 (2.0%) patient in Group A, with no statistically significant difference (p = 1.000). Conclusion Preoperative fibrinogen concentrations ≥ 3.3 g/L were associated with lower measured blood loss, lower whole-blood transfusion requirements, higher FFP requirements, more frequent prolonged inotropic support, and longer intensive care unit and postoperative hospital stays. Differences in re-exploration for bleeding, AKI, cardiac tamponade, and operative mortality were not statistically significant. These findings represent unadjusted associations and do not establish causality or independent prognostic value.
Source: Cureus
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7236181232
FWCI:
Cites: 16
Cited by:
Related to: 10